Mélanie Desbois
6PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 22, 2025
IGM-7354, an Immunocytokine with IL15 Fused to an Anti-PD-L1 IgM, Induces NK and CD8+ T cell-Mediated Cytotoxicity of PD-L1-Positive Tumor Cells.Mélanie Desbois, Thierry Giffon, Poonam Yakkundi
|Jun 02, 2021
Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.Mélanie Desbois, Yulei Wang
|Nov 05, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer.Mélanie Desbois, Akshata R Udyavar, Lisa Ryner
|Jun 14, 2020
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.Mélanie Desbois, Coralie Béal, Mélinda Charrier
|May 03, 2020
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.Clélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci
|May 25, 2016
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.Mélanie Desbois, Pauline Le Vu, Clélia Coutzac
Pageof 1
Frequent Collaborators
2 joint publications
Lydie Cassard
2 joint publications
Yulei Wang
1 joint publications
Pauline Le Vu
1 joint publications
Clélia Coutzac
1 joint publications
Elie Marcheteau
1 joint publications
Coralie Béal
1 joint publications
Sébastien Morisseau
1 joint publications
Lisa Boselli
1 joint publications
David Béchard
1 joint publications
Eric Tartour
